Autoimmune Disease Diagnostic Market, Global Forecast, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], by Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) By Regions (North America, Europe, Asia-Pacific &Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories)
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes misdirected and attacks the very organs it was designed to protect), thereby allowing the system to act up and attack healthy cells and tissues.
Autoimmune Disease Diagnostic Devices market is expected to witness substantial growth due to rising incidence of autoimmune diseases, Growing Rheumatoid Arthritisand technological advancements in diagnosis devices further boosts the demand for the industry over the forecast period.
Renub Research report titled “Autoimmune Disease Diagnostic Market, Global Forecast, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], by Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) By Regions (North America, Europe, Asia-Pacific &Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories)” provides a complete analysis of Global Autoimmune Disease Diagnostic Market.
By Disease
The report studies the market of the following segments: [Systemic autoimmune disease diagnostics market (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others) and Localized autoimmune disease diagnostics Market.
It is a very common diagnosis that helps to find immune diseases. With the rising incidence of autoimmune diseases in the several geographical regions and growing the number of Rheumatoid Arthritis, it is anticipated that the Autoimmune Disease Diagnostic market will grow in future.
By Test Type – Autoantibody Tests & CBC Tests have Bright Future
It is believed that in near future; Autoantibody Tests and Complete Blood Count Autoimmune Test will certainly rule the Autoimmune Disease Diagnostic Market. The report provides a detailed competitive landscaping Tests Market of Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis, Comprehensive Metabolic Panel and Others.
By Region – North America and Europe will drive the Autoimmune Disease Diagnostic Market
North America and Europe tend to have the considerable market in the Autoimmune Disease Diagnostic Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific and Rest of World Autoimmune Disease Diagnostic Market.
Companies Analysis
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points
Autoimmune Disease Diagnostic Segments Covered in the Report:
Systemic autoimmune disease diagnostics market
Regional Market Covered in the Report:
Autoimmune Disease Diagnostic Devices market is expected to witness substantial growth due to rising incidence of autoimmune diseases, Growing Rheumatoid Arthritisand technological advancements in diagnosis devices further boosts the demand for the industry over the forecast period.
Renub Research report titled “Autoimmune Disease Diagnostic Market, Global Forecast, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], by Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) By Regions (North America, Europe, Asia-Pacific &Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories)” provides a complete analysis of Global Autoimmune Disease Diagnostic Market.
By Disease
The report studies the market of the following segments: [Systemic autoimmune disease diagnostics market (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others) and Localized autoimmune disease diagnostics Market.
It is a very common diagnosis that helps to find immune diseases. With the rising incidence of autoimmune diseases in the several geographical regions and growing the number of Rheumatoid Arthritis, it is anticipated that the Autoimmune Disease Diagnostic market will grow in future.
By Test Type – Autoantibody Tests & CBC Tests have Bright Future
It is believed that in near future; Autoantibody Tests and Complete Blood Count Autoimmune Test will certainly rule the Autoimmune Disease Diagnostic Market. The report provides a detailed competitive landscaping Tests Market of Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis, Comprehensive Metabolic Panel and Others.
By Region – North America and Europe will drive the Autoimmune Disease Diagnostic Market
North America and Europe tend to have the considerable market in the Autoimmune Disease Diagnostic Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific and Rest of World Autoimmune Disease Diagnostic Market.
Companies Analysis
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Business Strategy /Mergers & Acquisition
- Financial Insight
Autoimmune Disease Diagnostic Segments Covered in the Report:
Systemic autoimmune disease diagnostics market
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)
- Others
Regional Market Covered in the Report:
- North America
- Europe
- Asia-Pacific
- Rest of World
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- EUROIMMUN AG
- bioMerieux SA
- Quest Diagnostic
- Bio-Rad Laboratories
1. EXECUTIVE SUMMARY
2. GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
3. MARKET SHARE – GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. BY DISEASE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
5. BY TEST TYPE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. BY REGION - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. ABBOTT LABORATORIES – COMPANY ANALYSIS
7.1 Overview
7.2 Business Strategy
7.2.1 Point A
7.2.2 Point B
7.2.3 Point C
7.2.4 Point D
7.3 Financial Insight
8. SIEMENS HEALTHINEERS – COMPANY ANALYSIS
8.1 Overview
8.2 Business Strategy
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.3 Financial Insight
9. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
9.1 Overview
9.2 Business Strategy
9.2.1 Point A
9.2.2 Point B
9.2.3 Point C
9.3 Financial Insight
10. EUROIMMUN AG – COMPANY ANALYSIS
10.1 Overview
10.2 Business Strategy
10.2.1 Point A
10.3 Financial Insight
11. BIOMERIEUX SA – COMPANY ANALYSIS
11.1 Overview
11.2 Business Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Financial Insight
12. QUEST DIAGNOSTIC – COMPANY ANALYSIS
12.1 Overview
12.2 Business Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.3 Financial Insight
13. BIO-RAD LABORATORIES – COMPANY ANALYSIS
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. GROWTH DRIVERS FOR AUTOIMMUNE DISEASE DIAGNOSTIC
14.1 Point No.
14.2 Point No.
15. CHALLENGES FOR AUTOIMMUNE DISEASE DIAGNOSTIC
15.1 Point No.
15.2 Point No.
2. GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
3. MARKET SHARE – GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. BY DISEASE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
5. BY TEST TYPE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. BY REGION - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. ABBOTT LABORATORIES – COMPANY ANALYSIS
7.1 Overview
7.2 Business Strategy
7.2.1 Point A
7.2.2 Point B
7.2.3 Point C
7.2.4 Point D
7.3 Financial Insight
8. SIEMENS HEALTHINEERS – COMPANY ANALYSIS
8.1 Overview
8.2 Business Strategy
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.3 Financial Insight
9. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
9.1 Overview
9.2 Business Strategy
9.2.1 Point A
9.2.2 Point B
9.2.3 Point C
9.3 Financial Insight
10. EUROIMMUN AG – COMPANY ANALYSIS
10.1 Overview
10.2 Business Strategy
10.2.1 Point A
10.3 Financial Insight
11. BIOMERIEUX SA – COMPANY ANALYSIS
11.1 Overview
11.2 Business Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Financial Insight
12. QUEST DIAGNOSTIC – COMPANY ANALYSIS
12.1 Overview
12.2 Business Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.3 Financial Insight
13. BIO-RAD LABORATORIES – COMPANY ANALYSIS
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. GROWTH DRIVERS FOR AUTOIMMUNE DISEASE DIAGNOSTIC
14.1 Point No.
14.2 Point No.
15. CHALLENGES FOR AUTOIMMUNE DISEASE DIAGNOSTIC
15.1 Point No.
15.2 Point No.
LIST OF FIGURES
Figure 2-1: Global Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2017
Figure 2-2: Forecast for Global Autoimmune Diseases Diagnostic Market (Billion US$), 2018 – 2024
Figure 3-1: By Product - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-2: By Product - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 3-3: By Diseases – Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-4: By Diseases - Forecast for Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 3-5: By Region - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-6: By Region – Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 4-1: Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-2: Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2018 - 2024
Figure 4-3: Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-4: Forecast for Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2018 - 2024
Figure 4-5: Ankylosing Spondylitis disease diagnostics market (Million US$), 2011 - 2017
Figure 4-6: Forecast for Ankylosing Spondylitis disease diagnostics market (Million US$), 2018 – 2024
Figure 4-7: Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2011 – 2017
Figure 4-8: Forecast for Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2018 – 2024
Figure 4-9: Others Systemic autoimmune disease diagnostics market (Billion US$), 2011 – 2017
Figure 4-10: Forecast for Other Systemic autoimmune disease diagnostics market (Billion US$), 2018 – 2024
Figure 4-11: Localized Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-12: Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2018 – 2024
Figure 5-1: Autoantibody Tests Market (Million US$), 2011 - 2017
Figure 5-2: Forecast for Autoantibody Tests Market (Million US$), 2018 – 2024
Figure 5-3: Antinuclear Antibody Tests Market (Million US$), 2011 - 2017
Figure 5-4: Forecast for Antinuclear Antibody Tests Market (Million US$), 2018 – 2024
Figure 5-5: Complete Blood Count Market (Million US$), 2011 – 2017
Figure 5-6: Forecast for Complete Blood Count Market (Million US$), 2018 – 2024
Figure 5-7: Erythrocyte Sedimentation Rate Market (Million US$), 2011 - 2017
Figure 5-8: Forecast for Erythrocyte Sedimentation Rate Market (Million US$), 2018 - 2024
Figure 5-9: C-reactive protein Test Market (Million US$), 2011 - 2017
Figure 5-10: Forecast for C-reactive protein Test Market (Million US$), 2018 - 2024
Figure 5-11: Urinalysis Market (Million US$), 2011 - 2017
Figure 5-12: Forecast for Urinalysis Market (Million US$), 2018 – 2024
Figure 5-13: Comprehensive Metabolic Panel Market (Million US$), 2011 - 2017
Figure 5-14: Forecast for Comprehensive Metabolic Panel Market (Million US$), 2018 - 2024
Figure 5-15: Others Autoimmune Diseases Test Market (Million US$), 2011 - 2017
Figure 5-16: Forecast for Others Autoimmune Diseases Test Market (Million US$), 2018 - 2024
Figure 6-1: North America Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2017
Figure 6-2: Forecast for North America Autoimmune Diseases Diagnostic Market (Billion US$), 2018 – 2024
Figure 6-3: Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-4: Forecast for Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 6-5: Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-6: Forecast for Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 6-7: Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-8: Forecast for Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 7-1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2011 – 2017
Figure 7-2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2018 – 2024
Figure 8-1: Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2011 – 2017
Figure 8-2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2018 – 2024
Figure 9-1: Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2011 – 2017
Figure 9-2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2018 – 2024
Figure 10-1: Euroimmun AG Net Sales (Million US$), 2011 – 2017
Figure 10-2: Forecast for Euroimmun AG Net Sales (Million US$), 2018 – 2024
Figure 11-1: biomerieux SA Net Sales (Million US$), 2011 – 2017
Figure 11-2: Forecast for biomerieux SA Net Sales (Million US$), 2018 – 2024
Figure 12-1: Quest Diagnostic Net Sales (Million US$), 2011 – 2017
Figure 12-2: Forecast for Quest Diagnostic Net Sales (Million US$), 2018 – 2024
Figure 13-1: Bio-Red Laboratories Net Sales (Million US$), 2011 – 2017
Figure 13-2: Forecast for Bio-Red Laboratories Net Sales (Million US$), 2018 – 2024
Figure 14-1: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries as of 2017
Figure 14-2: Arthritis in U.S (Million) 2017 – 2024
Figure 14-3: Prevalence of rheumatoid arthritis, by age and sex, 2014–15
Figure 2-1: Global Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2017
Figure 2-2: Forecast for Global Autoimmune Diseases Diagnostic Market (Billion US$), 2018 – 2024
Figure 3-1: By Product - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-2: By Product - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 3-3: By Diseases – Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-4: By Diseases - Forecast for Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 3-5: By Region - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2017
Figure 3-6: By Region – Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 4-1: Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-2: Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2018 - 2024
Figure 4-3: Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-4: Forecast for Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2018 - 2024
Figure 4-5: Ankylosing Spondylitis disease diagnostics market (Million US$), 2011 - 2017
Figure 4-6: Forecast for Ankylosing Spondylitis disease diagnostics market (Million US$), 2018 – 2024
Figure 4-7: Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2011 – 2017
Figure 4-8: Forecast for Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2018 – 2024
Figure 4-9: Others Systemic autoimmune disease diagnostics market (Billion US$), 2011 – 2017
Figure 4-10: Forecast for Other Systemic autoimmune disease diagnostics market (Billion US$), 2018 – 2024
Figure 4-11: Localized Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2017
Figure 4-12: Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2018 – 2024
Figure 5-1: Autoantibody Tests Market (Million US$), 2011 - 2017
Figure 5-2: Forecast for Autoantibody Tests Market (Million US$), 2018 – 2024
Figure 5-3: Antinuclear Antibody Tests Market (Million US$), 2011 - 2017
Figure 5-4: Forecast for Antinuclear Antibody Tests Market (Million US$), 2018 – 2024
Figure 5-5: Complete Blood Count Market (Million US$), 2011 – 2017
Figure 5-6: Forecast for Complete Blood Count Market (Million US$), 2018 – 2024
Figure 5-7: Erythrocyte Sedimentation Rate Market (Million US$), 2011 - 2017
Figure 5-8: Forecast for Erythrocyte Sedimentation Rate Market (Million US$), 2018 - 2024
Figure 5-9: C-reactive protein Test Market (Million US$), 2011 - 2017
Figure 5-10: Forecast for C-reactive protein Test Market (Million US$), 2018 - 2024
Figure 5-11: Urinalysis Market (Million US$), 2011 - 2017
Figure 5-12: Forecast for Urinalysis Market (Million US$), 2018 – 2024
Figure 5-13: Comprehensive Metabolic Panel Market (Million US$), 2011 - 2017
Figure 5-14: Forecast for Comprehensive Metabolic Panel Market (Million US$), 2018 - 2024
Figure 5-15: Others Autoimmune Diseases Test Market (Million US$), 2011 - 2017
Figure 5-16: Forecast for Others Autoimmune Diseases Test Market (Million US$), 2018 - 2024
Figure 6-1: North America Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2017
Figure 6-2: Forecast for North America Autoimmune Diseases Diagnostic Market (Billion US$), 2018 – 2024
Figure 6-3: Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-4: Forecast for Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 6-5: Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-6: Forecast for Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 6-7: Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2017
Figure 6-8: Forecast for Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2018 - 2024
Figure 7-1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2011 – 2017
Figure 7-2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2018 – 2024
Figure 8-1: Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2011 – 2017
Figure 8-2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2018 – 2024
Figure 9-1: Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2011 – 2017
Figure 9-2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2018 – 2024
Figure 10-1: Euroimmun AG Net Sales (Million US$), 2011 – 2017
Figure 10-2: Forecast for Euroimmun AG Net Sales (Million US$), 2018 – 2024
Figure 11-1: biomerieux SA Net Sales (Million US$), 2011 – 2017
Figure 11-2: Forecast for biomerieux SA Net Sales (Million US$), 2018 – 2024
Figure 12-1: Quest Diagnostic Net Sales (Million US$), 2011 – 2017
Figure 12-2: Forecast for Quest Diagnostic Net Sales (Million US$), 2018 – 2024
Figure 13-1: Bio-Red Laboratories Net Sales (Million US$), 2011 – 2017
Figure 13-2: Forecast for Bio-Red Laboratories Net Sales (Million US$), 2018 – 2024
Figure 14-1: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries as of 2017
Figure 14-2: Arthritis in U.S (Million) 2017 – 2024
Figure 14-3: Prevalence of rheumatoid arthritis, by age and sex, 2014–15
LIST OF TABLES
Table 4 1: Human Systemic Autoimmune Diseases
Table 4 2: Human Localized Autoimmune Diseases
Table 5 1: Normal Complete Blood Count Result
Table 8 1: Prevalence Data for Selected Autoimmune Diseases Listed - 2010
Table 8 2: US Prevalence Data for Selected Autoimmune Diseases Listed - 2012
Table 4 1: Human Systemic Autoimmune Diseases
Table 4 2: Human Localized Autoimmune Diseases
Table 5 1: Normal Complete Blood Count Result
Table 8 1: Prevalence Data for Selected Autoimmune Diseases Listed - 2010
Table 8 2: US Prevalence Data for Selected Autoimmune Diseases Listed - 2012
